Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys

An inactivated vaccine for severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) was evaluated in rhesus monkeys. The monkeys were inoculated intramuscularly (i.m.) with 0.5, 5, 50, or 5000 μg of vaccine, or PBS as control, and boosted on day 7. After 3 weeks, they were challeng...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Vaccine
Главные авторы: Zhou, Jun, Wang, Wei, Zhong, Qiong, Hou, Wei, Yang, Zhanqiu, Xiao, Shu-Yuan, Zhu, Runqing, Tang, Zhijiao, Wang, Yong, Xian, Qiaoyang, Tang, Hongbing, Wen, Li
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier Ltd. 2005
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115379/
https://ncbi.nlm.nih.gov/pubmed/15837221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2004.11.075
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы